Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : IMNR - Immune Response -- Ignore unavailable to you. Want to Upgrade?

To: John McCarthy who wrote (150)	10/29/1997 10:12:00 PM
From: MJ	Read Replies (1) \| Respond to of 1510

John: Gallo's research has queaked my interest in the past and now. Other than that I have no information or comment. Intuitively, I beieve that bio-tech is certainly one of the places to be. I need to do more research to identify those stocks I want to risk. One would like to think that Gallo's research will be meaningful to IMNR. MJ

To: John McCarthy who wrote (150)	10/30/1997 12:17:00 AM
From: Mark B. Martell, CCM	Read Replies (1) \| Respond to of 1510

That's irregardless to me John, It's one of the accepted values in our thread, IMHO, yet, OTOH, I can see your point. The question I have for you is did you understand the meaning? If so, then we have communicated. Good luck. The cash drain is strong on this company. That's why the principals infused additional capital into the corporation, taking on personal debt. They must believe in it or they would have sought external convertible debt, diluting the shares to the nth degree. My guess is that they know something.... Mark